Prognosis
U.K. Deploys Fastest Supercomputer to Fight Dementia, MS
- Developed in partnership with AstraZeneca, GlaxoSmithKline
- Nvidia waitng for approval for its $40 billion takeover of Arm
This article is for subscribers only.
Nvidia Corp. has built a U.K. supercomputer for scientists and drug makers that will allow researchers to model diseases, discover new medicines and advance knowledge of the human genome.
The Cambridge-1 will be the country’s most powerful and one of the top 50 supercomputers worldwide. It was developed in partnership with AstraZeneca Plc and GlaxoSmithKline Plc, Nvidia said in a statement on Wednesday.